Troutman Pepper Locke attorneys examine how cell and gene therapies are reshaping deal terms, regulatory strategy, and IP.
| less than a minute read
Rewriting the Life Sciences Collaboration Playbook: How Cell and Gene Therapies Are Reshaping Deal Terms, Regulatory Strategy, and IP

/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-10-23-17-11-55-792-6adb955b072522557d3e5da4.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-10-23-13-31-08-767-6adb619cbd29a7ce1f64a3bb.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-10-23-13-32-33-401-6adb61f14e7423698f02bc8c.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-10-23-13-31-57-294-6adb61cdc440b9d587264829.jpg)